E

Exavir Therapeutics

10 employees

Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2020

Funding rounds raised

Total raised

$4M

from 3 investors over 3 rounds

E

Exavir Therapeutics raised $3M on August 22, 2023

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

E

Exavir Therapeutics raised $4M on May 23, 2022

Investors: AlleyCorp and Gilead Sciences

FAQ